Trial intelligence / Profile preview

Fenticonazole nitrate vaginal suppository for vulvovaginal candidiasis (dose and duration exploration)

CTR20131279Phase 2Active

Sponsor
Shandong Truilin Pharmaceutical Technology Development
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fenticonazole in vulvovaginal candidiasis (VVC), sponsored by Shandong Truilin Pharmaceutical Technology Development. Started Nov 2013; status: active.

02

Drugs

fenticonazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on CTR20131279.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131279.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call